Literature DB >> 15506774

A synthesis strategy yielding skeletally diverse small molecules combinatorially.

Martin D Burke1, Eric M Berger, Stuart L Schreiber.   

Abstract

The efficient synthesis of small molecules having many molecular skeletons is an unsolved problem in diversity-oriented synthesis (DOS). We describe the development and application of a synthesis strategy that uses common reaction conditions to transform a collection of similar substrates into a collection of products having distinct molecular skeletons. The substrates have different appendages that pre-encode skeletal information, called sigma-elements. This approach is analogous to the natural process of protein folding in which different primary sequences of amino acids are transformed into macromolecules having distinct three-dimensional structures under common folding conditions. Like sigma-elements, the amino acid sequences pre-encode structural information. An advantage of using folding processes to generate skeletal diversity in DOS is that skeletal information can be pre-encoded into substrates in a combinatorial fashion, similar to the way protein structural information is pre-encoded combinatorially in polypeptide sequences, thus making it possible to generate skeletal diversity in an efficient manner. This efficiency was realized in the context of a fully encoded, split-pool synthesis of approximately 1260 compounds potentially representing all possible combinations of building block, stereochemical, and skeletal diversity elements.

Mesh:

Substances:

Year:  2004        PMID: 15506774     DOI: 10.1021/ja0457415

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  29 in total

Review 1.  Virtual screening: an endless staircase?

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

2.  Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.

Authors:  Warren R J D Galloway; Albert Isidro-Llobet; David R Spring
Journal:  Nat Commun       Date:  2010-09-21       Impact factor: 14.919

3.  Screening of a one bead-one compound combinatorial library for beta-actin identifies molecules active toward Ramos B-lymphoma cells.

Authors:  Suzanne Miyamoto; Ruiwu Liu; Susan Hung; Xiaobing Wang; Kit S Lam
Journal:  Anal Biochem       Date:  2007-10-24       Impact factor: 3.365

4.  A road less traveled by: exploring a decade of Ellman chemistry.

Authors:  Anang A Shelat; R Kiplin Guy
Journal:  Bioorg Med Chem       Date:  2008-03-04       Impact factor: 3.641

5.  Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli.

Authors:  Effendi Leonard; Kok-Hong Lim; Phan-Nee Saw; Mattheos A G Koffas
Journal:  Appl Environ Microbiol       Date:  2007-04-27       Impact factor: 4.792

Review 6.  Chemical probes and drug leads from advances in synthetic planning and methodology.

Authors:  Christopher J Gerry; Stuart L Schreiber
Journal:  Nat Rev Drug Discov       Date:  2018-04-13       Impact factor: 84.694

Review 7.  Neurobiological applications of small molecule screening.

Authors:  Andras Bauer; Brent Stockwell
Journal:  Chem Rev       Date:  2008-05-01       Impact factor: 60.622

8.  A concise asymmetric total synthesis of (+)-brevisamide.

Authors:  Aaron T Herrmann; Steven R Martinez; Armen Zakarian
Journal:  Org Lett       Date:  2011-06-16       Impact factor: 6.005

9.  Diversity through a branched reaction pathway: generation of multicyclic scaffolds and identification of antimigratory agents.

Authors:  Zhiming Wang; Sabrina Castellano; Sape S Kinderman; Christian E Argueta; Anwar B Beshir; Gabriel Fenteany; Ohyun Kwon
Journal:  Chemistry       Date:  2010-11-09       Impact factor: 5.236

10.  A tandem isomerization/prins strategy: iridium(III)/Brønsted acid cooperative catalysis.

Authors:  Vince M Lombardo; Christopher D Thomas; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-11       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.